Clinical Trials Browser

Phase 1/2 × avelumab × Endocrine × Clear all

NCT04261855 2026-03-27

GoTHAM

Phase 1/2 Active not recruiting

DermatologicEndocrineNET

Carcinoma, Carcinoma, Merkel Cell, Neuroendocrine Tumors

NCT03278405 2020-03-18

NET-001

Phase 1/2 Completed

Carcinoma, Neuroendocrine